<a href="https://laohu8.com/S/FOXO">FOXO Technologies Inc.</a> Faces Delisting from NYSE American Due to Low Stock Price; Moves to OTC Market
FOXO Technologies Inc., a Delaware corporation, announced on August 12, 2025, that its Class A Common Stock will be delisted from the NYSE American due to its low selling price, which fell below the $0.10 minimum threshold. Trading was suspended immediately by NYSE. The company has since received confirmation from FINRA's Department of Market Operations that its stock will trade on the OTC market under the symbol "FOXO" starting August 13, 2025. Additionally, FOXO Technologies disclosed that its board of directors determined previous financial statements from its Quarterly Report ended March 31, 2025, should not be relied upon due to an error related to the accounting for purchase price consideration in connection with its acquisition of Rennova Community Health, Inc. The company plans to amend its financial statements to address this issue.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-024660), on August 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.